ArticlePharmaceuticals (Basel, Switzerland)2026
Alpha Therapy Beyond TOC and TATE-Production, Quality Control, and In-Human Results for the SSTR2 Antagonist DOTA-LM3.
Lukas Greifenstein et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.